Bangalore, India I June 5, 2025

Cambrian Bioworks is proud to announce that Manta, its fully automated nucleic acid extraction platform, has received CE-IVD certification under Regulation (EU) 2017/746 (IVDR). This designation affirms Manta’s readiness for use in regulated diagnostic workflows across the EU and other CE-recognizing countries.

In clinical settings, small inconsistencies in sample preparation can have outsized consequences, leading to re-runs, delayed reporting, or uncertainty in borderline cases. With the stakes higher than ever in areas like oncology, infectious disease, transplant medicine, and rare disease diagnostics, dependable extraction is foundational to accurate results.

Manta addresses these risks head-on. Its cartridge-based workflow, magnetic bead chemistry, and flexible throughput (1–32 samples per run) are engineered to deliver clean, high-yield DNA without batch constraints or manual intervention. With CE-IVD certification, Manta now meets the stringent performance and manufacturing standards required for in vitro diagnostic use, ensuring clinical labs can integrate it with confidence.

This certification underscores our commitment to building tools that labs can rely on every day. Manta is already delivering robust DNA extractions in high-throughput and specialized settings. Now, it’s also certified for regulated diagnostics, helping labs scale with both speed and confidence,

said Vaibhav Hegde, CEO, Cambrian Bioworks.

This milestone also reflects Manta’s proven versatility across diverse and challenging clinical sample types, including fresh whole blood, FFPE tissues, stool, and even low-yield or degraded specimens. In many diagnostic workflows, these inputs come with unpredictable quality and complex matrices that can hinder extraction. Manta’s automated chemistry and closed-cartridge design minimize variability while maintaining biosafety, making it a dependable upstream solution for labs handling everything from routine panels to rare disease investigations. By enabling high-quality DNA extraction across specimen types, Manta positions itself as a cornerstone for modern clinical genomics.

About Cambrian Bioworks

Cambrian Bioworks develops automation-first molecular technologies for clinical genomics. With a focus on reliability, usability, and innovation, Cambrian is enabling the next generation of diagnostic labs through robust hardware and scalable systems.